Details for Patent: 8,547,248
✉ Email this page to a colleague
Which drugs does patent 8,547,248 protect, and when does it expire?
Patent 8,547,248 protects ABILIFY MYCITE KIT and is included in one NDA.
This patent has one hundred and twenty-five patent family members in twenty-two countries.
Summary for Patent: 8,547,248
Title: | Implantable zero-wire communications system |
Abstract: | The present invention provides implantable systems that communicate wirelessly with each other using a unique format that enables devices configurations and applications heretofore not possible. Embodiments of the present invention provide communication apparatuses and methods for exchanging information with implantable medical devices. In some embodiments, two implantable devices communicate with each other using quasi-electrostatic signal transmission in a long wavelength/low frequency electromagnetic band, with the patient's body acting as a conductive medium. |
Inventor(s): | Zdeblick; Mark J. (Portola Valley, CA), Robertson; Timothy (Belmont, CA) |
Assignee: | Proteus Digital Health, Inc. (Redwood City, CA) |
Application Number: | 12/063,095 |
Patent Claim Types: see list of patent claims | Use; Delivery; Device; |
Patent landscape, scope, and claims: | More… ↓ |
Drugs Protected by US Patent 8,547,248
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Otsuka | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-001 | Nov 13, 2017 | RX | Yes | No | 8,547,248 | ⤷ Subscribe | Y | METHOD OF USING A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER | ⤷ Subscribe | |||
Otsuka | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-002 | Nov 13, 2017 | RX | Yes | Yes | 8,547,248 | ⤷ Subscribe | Y | METHOD OF USING A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER | ⤷ Subscribe | |||
Otsuka | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-003 | Nov 13, 2017 | RX | Yes | No | 8,547,248 | ⤷ Subscribe | Y | METHOD OF USING A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER | ⤷ Subscribe | |||
Otsuka | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-004 | Nov 13, 2017 | RX | Yes | No | 8,547,248 | ⤷ Subscribe | Y | METHOD OF USING A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,547,248
PCT Information | |||
PCT Filed | September 01, 2006 | PCT Application Number: | PCT/US2006/034258 |
PCT Publication Date: | March 08, 2007 | PCT Publication Number: | WO2007/028035 |
International Family Members for US Patent 8,547,248
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2006239221 | ⤷ Subscribe | |||
Australia | 2012282690 | ⤷ Subscribe | |||
Australia | 2012282772 | ⤷ Subscribe | |||
Australia | 2012282776 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |